Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIANO-6: Ticagrelor Dose and Anti-inflammatory Effect in ESRD on Hemodialysis
NCT02406911Phase 3Unknown
- Sponsor
- Kyung Hee University Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in chronic kidney disease (CKD), end stage renal disease (ESRD), sponsored by Kyung Hee University Medical Center. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
chronic kidney disease (CKD)end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02406911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406911.